THERA patient support® Program

THERA patient support® Program

THERA patient support® Program:
There for you and your patients every step of the way

THERA patient support® is a personalized patient support program for HCPs and patients.

  • By enrolling your patients in the THERA patient support® Program, your patients will receive the support they need throughout their EGRIFTA SV® treatment journey.
  • By streamlining treatment access and removing barriers to care, THERA patient support® is here to support you, your staff, and your patients every step of the way.

For questions on enrolling your patients and getting them started on EGRIFTA SV®, call the THERA patient support® line at 1-833-23-THERA/1-833-238-4372 and a THERA Patient Care Coordinator will assist you and your office staff.

Available Monday to Friday from 8:30 AM – 8:00 PM EST.

Benefits to Patients Enrolled in the THERA patient support® Program

Coverage and insurance support

Insurance coverage verification, help navigate prior authorizations, appeals and fulfillment process, educate on payer requirements and necessary documentation for personalized patient support.

Financial Assistance Program to help cover the cost of care

Commercial Insurance


THERA’s EGRIFTA SV® Co‑Pay Program may help patients with private or commercial insurance lower their out‑of‑pocket cost.

Government Insurance


THERA patient support® can assist with alternative funding for patients with government insurance that may lower their out‑of‑pocket cost.

Patient Assistance Program


The THERA Patient Assistance Program offers qualifying patients THERA medications at no cost.

Injection training with a THERA Nurse Navigator

Guaranteed injection training by one of THERA’s Nurse Navigators. Training is available virtually through video or by telephone.

Meet the THERA patient support® Team

THERA Patient Care Coordinators

  • Provide patients a welcome call, sharps container, and patient resource kit
  • Verify specific insurance coverage and reimbursement solutions
  • Assist with prior authorization and claim denials/appeals
  • If eligible, will enroll patients in the EGRIFTA SV® Co‑Pay Assistance Program
  • Explore financial assistance programs that may help cover the cost of care for your patients

Our goal is to secure access to treatment for your patients in a seamless single point of contact allowing you to focus on your patient’s care.

To request your THERA Patient Care Coordinator, contact 1-833-23-THERA/1-833-238-4372.

THERA Field Reimbursement Managers

  • Can answer questions about the THERA patient support® Program including the enrollment process and general reimbursement questions
  • Will educate on payer coverage criteria and policy updates
  • Assist with prior authorization and claim denials/appeals

Schedule a remote or live appointment with a THERA Field Reimbursement manager.

To request your THERA Field Reimbursement Manager, contact 1-833-23-THERA/1-833-238-4372.

THERA Nurse Navigators

Our professionally trained and experienced Nurse Navigators are there to provide your patients with personalized one‑on‑one nursing support. THERA Nurse Navigators will:

  • Welcome patients into the THERA patient support® Program and coordinate calls and/or video meetings based on patient’s schedule and preference
  • Offer virtual step‑by‑step reconstitution and administration training
  • Facilitate patient adherence through scheduled touch points
  • Support answering any product‑related questions
  • THERA Nurse Navigators are a resource for your patients to call with any questions or concerns

Our Nurse Navigators will partner with you and your patients to ensure a successful treatment journey while on EGRIFTA SV®.

For questions on enrolling your patients and getting them started on EGRIFTA SV®, call the THERA patient support® line at 1-833-23-THERA/1-833-238-4372 and a THERA Patient Care Coordinator will assist you and your office staff.

Available Monday to Friday from 8:30 AM – 8:00 PM EST.

2 easy options to enroll your patients

Once you have identified an appropriate patient for EGRIFTA SV®, here are the 2 ways to enroll them in the THERA patient support® Program:

2

Online prescribing and registering through the Physician Portal

Access the Physician Portal

  • Click the "Login" button and enter your credentials; or if you have not yet registered, select the "Register" button to create an account
  • Upload the enrollment form including the signed patient consent section
  • Upload chart notes and track patient real‑time enrollment status
  • Obtain coverage information and view product shipment information

Important note: To ensure your patients can immediately get started on EGRIFTA SV® therapy, it is important to get your patients’ signature/consent on the last page of the enrollment form

Once enrolled, a THERA Patient Care Coordinator will contact your patient to welcome them and start the process of coverage and reimbursement investigation.

Once approved, THERA patient support® will then coordinate with specialty pharmacies in their insurance network, so that your patients can quickly get started on EGRIFTA SV®.

Have questions? Connect with a THERA Patient Care Coordinator who can assist in enrolling your patients, verify insurance coverage, prior authorization support, and more.

Call THERA patient support® to enroll your patients 1‑833‑23THERA (1‑833‑238-4372), available Monday‑Friday 8:30AM-8:00PM EST



To report SUSPECTED ADVERSE REACTIONS, contact THERA patient support® toll free at 1‑833‑23THERA (1‑833‑238-4372) or FDA at 1‑800‑FDA-1088 or www.fda.gov/medwatch.

IMPORTANT SAFETY INFORMATION (Please see below for full limitations of use and additional important safety information)

Indication

EGRIFTA SV® is indicated for the reduction of excess abdominal fat in HIV‑infected adult patients with lipodystrophy.

Limitations of Use:

  • The impact and safety of EGRIFTA SV® on cardiovascular health have not been studied.
  • EGRIFTA SV® is not indicated for weight loss management.
  • It is not known whether taking EGRIFTA SV® helps improve compliance with anti‑retroviral medications.

Contraindications:

Do not use EGRIFTA SV® if patient:

  • Has a pituitary gland tumor, has had pituitary gland surgery, has other problems related to their pituitary gland, or has had radiation treatment to their head or a head injury.
  • Has active cancer.
  • Is allergic to tesamorelin or any of the ingredients in EGRIFTA SV®.
  • Is pregnant or planning to become pregnant.

Warnings and Precautions

Drug Interactions

Use in Specific Populations

Adverse Reactions

The most commonly reported adverse reactions include injection site reactions, arthralgia, pain in extremity, myalgia, and peripheral edema.

To report suspected adverse reactions, contact THERA patient support® at 1‑833‑23THERA (1‑833‑238-4372) or FDA at 1‑800‑FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information for EGRIFTA SV®.